1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Dosage Form 1.2.1 Global Musculoskeletal Medicine Market Size Growth Rate by Dosage Form: 2017 VS 2021 VS 2028 1.2.2 Tablets 1.2.3 Patch 1.2.4 Capsule 1.2.5 Suppositories 1.2.6 Injection 1.2.7 Suspension Agent 1.2.8 Emplastrum 1.2.9 Granules 1.2.10 Other 1.3 Market by Application 1.3.1 Global Musculoskeletal Medicine Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Orthopedic Analgesics 1.3.3 Antipyretic And Analgesic 1.3.4 Nonsteroidal Anti-Inflammatory Drugs 1.3.5 Drugs For Rheumatic Diseases 1.3.6 Gout Drug Resistance 1.3.7 Medication For Bruising Injuries 1.3.8 Myasthenia Gravis Medication 1.3.9 Slow Acting Antirheumatic Agent 1.3.10 Topical Administration For Joint And Muscle Pain 1.3.11 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Musculoskeletal Medicine Market Perspective (2017-2028) 2.2 Musculoskeletal Medicine Growth Trends by Region 2.2.1 Musculoskeletal Medicine Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Musculoskeletal Medicine Historic Market Size by Region (2017-2022) 2.2.3 Musculoskeletal Medicine Forecasted Market Size by Region (2023-2028) 2.3 Musculoskeletal Medicine Market Dynamics 2.3.1 Musculoskeletal Medicine Industry Trends 2.3.2 Musculoskeletal Medicine Market Drivers 2.3.3 Musculoskeletal Medicine Market Challenges 2.3.4 Musculoskeletal Medicine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Musculoskeletal Medicine Players by Revenue 3.1.1 Global Top Musculoskeletal Medicine Players by Revenue (2017-2022) 3.1.2 Global Musculoskeletal Medicine Revenue Market Share by Players (2017-2022) 3.2 Global Musculoskeletal Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Musculoskeletal Medicine Revenue 3.4 Global Musculoskeletal Medicine Market Concentration Ratio 3.4.1 Global Musculoskeletal Medicine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal Medicine Revenue in 2021 3.5 Musculoskeletal Medicine Key Players Head office and Area Served 3.6 Key Players Musculoskeletal Medicine Product Solution and Service 3.7 Date of Enter into Musculoskeletal Medicine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Musculoskeletal Medicine Breakdown Data by Type 4.1 Global Musculoskeletal Medicine Historic Market Size by Type (2017-2022) 4.2 Global Musculoskeletal Medicine Forecasted Market Size by Type (2023-2028) 5 Musculoskeletal Medicine Breakdown Data by Application 5.1 Global Musculoskeletal Medicine Historic Market Size by Application (2017-2022) 5.2 Global Musculoskeletal Medicine Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Musculoskeletal Medicine Market Size (2017-2028) 6.2 North America Musculoskeletal Medicine Market Size by Country (2017-2022) 6.3 North America Musculoskeletal Medicine Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Musculoskeletal Medicine Market Size (2017-2028) 7.2 Europe Musculoskeletal Medicine Market Size by Country (2017-2022) 7.3 Europe Musculoskeletal Medicine Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Musculoskeletal Medicine Market Size (2017-2028) 8.2 Asia-Pacific Musculoskeletal Medicine Market Size by Country (2017-2022) 8.3 Asia-Pacific Musculoskeletal Medicine Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Musculoskeletal Medicine Market Size (2017-2028) 9.2 Latin America Musculoskeletal Medicine Market Size by Country (2017-2022) 9.3 Latin America Musculoskeletal Medicine Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Musculoskeletal Medicine Market Size (2017-2028) 10.2 Middle East & Africa Musculoskeletal Medicine Market Size by Country (2017-2022) 10.3 Middle East & Africa Musculoskeletal Medicine Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Mylan N.V. 11.1.1 Mylan N.V. Company Detail 11.1.2 Mylan N.V. Business Overview 11.1.3 Mylan N.V. Musculoskeletal Medicine Introduction 11.1.4 Mylan N.V. Revenue in Musculoskeletal Medicine Business (2017-2022) 11.1.5 Mylan N.V. Recent Development 11.2 Teva Pharmaceutical Industries Ltd 11.2.1 Teva Pharmaceutical Industries Ltd Company Detail 11.2.2 Teva Pharmaceutical Industries Ltd Business Overview 11.2.3 Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Introduction 11.2.4 Teva Pharmaceutical Industries Ltd Revenue in Musculoskeletal Medicine Business (2017-2022) 11.2.5 Teva Pharmaceutical Industries Ltd Recent Development 11.3 UCB S.A. 11.3.1 UCB S.A. Company Detail 11.3.2 UCB S.A. Business Overview 11.3.3 UCB S.A. Musculoskeletal Medicine Introduction 11.3.4 UCB S.A. Revenue in Musculoskeletal Medicine Business (2017-2022) 11.3.5 UCB S.A. Recent Development 11.4 Novartis Pharmaceuticals 11.4.1 Novartis Pharmaceuticals Company Detail 11.4.2 Novartis Pharmaceuticals Business Overview 11.4.3 Novartis Pharmaceuticals Musculoskeletal Medicine Introduction 11.4.4 Novartis Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2017-2022) 11.4.5 Novartis Pharmaceuticals Recent Development 11.5 Roche Inc 11.5.1 Roche Inc Company Detail 11.5.2 Roche Inc Business Overview 11.5.3 Roche Inc Musculoskeletal Medicine Introduction 11.5.4 Roche Inc Revenue in Musculoskeletal Medicine Business (2017-2022) 11.5.5 Roche Inc Recent Development 11.6 Hospira Inc 11.6.1 Hospira Inc Company Detail 11.6.2 Hospira Inc Business Overview 11.6.3 Hospira Inc Musculoskeletal Medicine Introduction 11.6.4 Hospira Inc Revenue in Musculoskeletal Medicine Business (2017-2022) 11.6.5 Hospira Inc Recent Development 11.7 Valeant Pharmaceuticals International, Inc 11.7.1 Valeant Pharmaceuticals International, Inc Company Detail 11.7.2 Valeant Pharmaceuticals International, Inc Business Overview 11.7.3 Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Introduction 11.7.4 Valeant Pharmaceuticals International, Inc Revenue in Musculoskeletal Medicine Business (2017-2022) 11.7.5 Valeant Pharmaceuticals International, Inc Recent Development 11.8 Dr. Reddy's Laboratories Ltd. 11.8.1 Dr. Reddy's Laboratories Ltd. Company Detail 11.8.2 Dr. Reddy's Laboratories Ltd. Business Overview 11.8.3 Dr. Reddy's Laboratories Ltd. Musculoskeletal Medicine Introduction 11.8.4 Dr. Reddy's Laboratories Ltd. Revenue in Musculoskeletal Medicine Business (2017-2022) 11.8.5 Dr. Reddy's Laboratories Ltd. Recent Development 11.9 Sun Pharmaceutical Industries Ltd. Co. , Ltd 11.9.1 Sun Pharmaceutical Industries Ltd. Co. , Ltd Company Detail 11.9.2 Sun Pharmaceutical Industries Ltd. Co. , Ltd Business Overview 11.9.3 Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Introduction 11.9.4 Sun Pharmaceutical Industries Ltd. Co. , Ltd Revenue in Musculoskeletal Medicine Business (2017-2022) 11.9.5 Sun Pharmaceutical Industries Ltd. Co. , Ltd Recent Development 11.10 Sawai PharmaceuticalCo., Ltd 11.10.1 Sawai PharmaceuticalCo., Ltd Company Detail 11.10.2 Sawai PharmaceuticalCo., Ltd Business Overview 11.10.3 Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Introduction 11.10.4 Sawai PharmaceuticalCo., Ltd Revenue in Musculoskeletal Medicine Business (2017-2022) 11.10.5 Sawai PharmaceuticalCo., Ltd Recent Development 11.11 Endo International 11.11.1 Endo International Company Detail 11.11.2 Endo International Business Overview 11.11.3 Endo International Musculoskeletal Medicine Introduction 11.11.4 Endo International Revenue in Musculoskeletal Medicine Business (2017-2022) 11.11.5 Endo International Recent Development 11.12 Hikma Pharmaceuticals 11.12.1 Hikma Pharmaceuticals Company Detail 11.12.2 Hikma Pharmaceuticals Business Overview 11.12.3 Hikma Pharmaceuticals Musculoskeletal Medicine Introduction 11.12.4 Hikma Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2017-2022) 11.12.5 Hikma Pharmaceuticals Recent Development 11.13 Fresenius Kabi, LLC 11.13.1 Fresenius Kabi, LLC Company Detail 11.13.2 Fresenius Kabi, LLC Business Overview 11.13.3 Fresenius Kabi, LLC Musculoskeletal Medicine Introduction 11.13.4 Fresenius Kabi, LLC Revenue in Musculoskeletal Medicine Business (2017-2022) 11.13.5 Fresenius Kabi, LLC Recent Development 11.14 Boehringer Ingelheim 11.14.1 Boehringer Ingelheim Company Detail 11.14.2 Boehringer Ingelheim Business Overview 11.14.3 Boehringer Ingelheim Musculoskeletal Medicine Introduction 11.14.4 Boehringer Ingelheim Revenue in Musculoskeletal Medicine Business (2017-2022) 11.14.5 Boehringer Ingelheim Recent Development 11.15 Merck 11.15.1 Merck Company Detail 11.15.2 Merck Business Overview 11.15.3 Merck Musculoskeletal Medicine Introduction 11.15.4 Merck Revenue in Musculoskeletal Medicine Business (2017-2022) 11.15.5 Merck Recent Development 11.16 GSK 11.16.1 GSK Company Detail 11.16.2 GSK Business Overview 11.16.3 GSK Musculoskeletal Medicine Introduction 11.16.4 GSK Revenue in Musculoskeletal Medicine Business (2017-2022) 11.16.5 GSK Recent Development 11.17 Alter 11.17.1 Alter Company Detail 11.17.2 Alter Business Overview 11.17.3 Alter Musculoskeletal Medicine Introduction 11.17.4 Alter Revenue in Musculoskeletal Medicine Business (2017-2022) 11.17.5 Alter Recent Development 11.18 Bayer 11.18.1 Bayer Company Detail 11.18.2 Bayer Business Overview 11.18.3 Bayer Musculoskeletal Medicine Introduction 11.18.4 Bayer Revenue in Musculoskeletal Medicine Business (2017-2022) 11.18.5 Bayer Recent Development 11.19 Rafa Laboratories 11.19.1 Rafa Laboratories Company Detail 11.19.2 Rafa Laboratories Business Overview 11.19.3 Rafa Laboratories Musculoskeletal Medicine Introduction 11.19.4 Rafa Laboratories Revenue in Musculoskeletal Medicine Business (2017-2022) 11.19.5 Rafa Laboratories Recent Development 11.20 Grunenthal 11.20.1 Grunenthal Company Detail 11.20.2 Grunenthal Business Overview 11.20.3 Grunenthal Musculoskeletal Medicine Introduction 11.20.4 Grunenthal Revenue in Musculoskeletal Medicine Business (2017-2022) 11.20.5 Grunenthal Recent Development 11.21 Pfizer 11.21.1 Pfizer Company Detail 11.21.2 Pfizer Business Overview 11.21.3 Pfizer Musculoskeletal Medicine Introduction 11.21.4 Pfizer Revenue in Musculoskeletal Medicine Business (2017-2022) 11.21.5 Pfizer Recent Development 11.22 Sanofi 11.22.1 Sanofi Company Detail 11.22.2 Sanofi Business Overview 11.22.3 Sanofi Musculoskeletal Medicine Introduction 11.22.4 Sanofi Revenue in Musculoskeletal Medicine Business (2017-2022) 11.22.5 Sanofi Recent Development 11.23 Italfarmaco 11.23.1 Italfarmaco Company Detail 11.23.2 Italfarmaco Business Overview 11.23.3 Italfarmaco Musculoskeletal Medicine Introduction 11.23.4 Italfarmaco Revenue in Musculoskeletal Medicine Business (2017-2022) 11.23.5 Italfarmaco Recent Development 11.24 Martec USA LLC 11.24.1 Martec USA LLC Company Detail 11.24.2 Martec USA LLC Business Overview 11.24.3 Martec USA LLC Musculoskeletal Medicine Introduction 11.24.4 Martec USA LLC Revenue in Musculoskeletal Medicine Business (2017-2022) 11.24.5 Martec USA LLC Recent Development 11.25 Acorda Therapeutics 11.25.1 Acorda Therapeutics Company Detail 11.25.2 Acorda Therapeutics Business Overview 11.25.3 Acorda Therapeutics Musculoskeletal Medicine Introduction 11.25.4 Acorda Therapeutics Revenue in Musculoskeletal Medicine Business (2017-2022) 11.25.5 Acorda Therapeutics Recent Development 11.26 Apotex Inc 11.26.1 Apotex Inc Company Detail 11.26.2 Apotex Inc Business Overview 11.26.3 Apotex Inc Musculoskeletal Medicine Introduction 11.26.4 Apotex Inc Revenue in Musculoskeletal Medicine Business (2017-2022) 11.26.5 Apotex Inc Recent Development 11.27 CorePharma 11.27.1 CorePharma Company Detail 11.27.2 CorePharma Business Overview 11.27.3 CorePharma Musculoskeletal Medicine Introduction 11.27.4 CorePharma Revenue in Musculoskeletal Medicine Business (2017-2022) 11.27.5 CorePharma Recent Development 11.28 Helsinn 11.28.1 Helsinn Company Detail 11.28.2 Helsinn Business Overview 11.28.3 Helsinn Musculoskeletal Medicine Introduction 11.28.4 Helsinn Revenue in Musculoskeletal Medicine Business (2017-2022) 11.28.5 Helsinn Recent Development 11.29 Therabel 11.29.1 Therabel Company Detail 11.29.2 Therabel Business Overview 11.29.3 Therabel Musculoskeletal Medicine Introduction 11.29.4 Therabel Revenue in Musculoskeletal Medicine Business (2017-2022) 11.29.5 Therabel Recent Development 11.30 Sinopharm 11.30.1 Sinopharm Company Detail 11.30.2 Sinopharm Business Overview 11.30.3 Sinopharm Musculoskeletal Medicine Introduction 11.30.4 Sinopharm Revenue in Musculoskeletal Medicine Business (2017-2022) 11.30.5 Sinopharm Recent Development 11.31 Chinoin 11.31.1 Chinoin Company Detail 11.31.2 Chinoin Business Overview 11.31.3 Chinoin Musculoskeletal Medicine Introduction 11.31.4 Chinoin Revenue in Musculoskeletal Medicine Business (2017-2022) 11.31.5 Chinoin Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Musculoskeletal Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Tablets Table 3. Key Players of Patch Table 4. Key Players of Capsule Table 5. Key Players of Suppositories Table 6. Key Players of Injection Table 7. Key Players of Suspension Agent Table 8. Key Players of Emplastrum Table 9. Key Players of Granules Table 10. Key Players of Other Table 11. Global Musculoskeletal Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 12. Global Musculoskeletal Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 13. Global Musculoskeletal Medicine Market Size by Region (2017-2022) & (US$ Million) Table 14. Global Musculoskeletal Medicine Market Share by Region (2017-2022) Table 15. Global Musculoskeletal Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 16. Global Musculoskeletal Medicine Market Share by Region (2023-2028) Table 17. Musculoskeletal Medicine Market Trends Table 18. Musculoskeletal Medicine Market Drivers Table 19. Musculoskeletal Medicine Market Challenges Table 20. Musculoskeletal Medicine Market Restraints Table 21. Global Musculoskeletal Medicine Revenue by Players (2017-2022) & (US$ Million) Table 22. Global Musculoskeletal Medicine Market Share by Players (2017-2022) Table 23. Global Top Musculoskeletal Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Medicine as of 2021) Table 24. Ranking of Global Top Musculoskeletal Medicine Companies by Revenue (US$ Million) in 2021 Table 25. Global 5 Largest Players Market Share by Musculoskeletal Medicine Revenue (CR5 and HHI) & (2017-2022) Table 26. Key Players Headquarters and Area Served Table 27. Key Players Musculoskeletal Medicine Product Solution and Service Table 28. Date of Enter into Musculoskeletal Medicine Market Table 29. Mergers & Acquisitions, Expansion Plans Table 30. Global Musculoskeletal Medicine Market Size by Type (2017-2022) & (US$ Million) Table 31. Global Musculoskeletal Medicine Revenue Market Share by Type (2017-2022) Table 32. Global Musculoskeletal Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 33. Global Musculoskeletal Medicine Revenue Market Share by Type (2023-2028) Table 34. Global Musculoskeletal Medicine Market Size by Application (2017-2022) & (US$ Million) Table 35. Global Musculoskeletal Medicine Revenue Market Share by Application (2017-2022) Table 36. Global Musculoskeletal Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 37. Global Musculoskeletal Medicine Revenue Market Share by Application (2023-2028) Table 38. North America Musculoskeletal Medicine Market Size by Country (2017-2022) & (US$ Million) Table 39. North America Musculoskeletal Medicine Market Size by Country (2023-2028) & (US$ Million) Table 40. Europe Musculoskeletal Medicine Market Size by Country (2017-2022) & (US$ Million) Table 41. Europe Musculoskeletal Medicine Market Size by Country (2023-2028) & (US$ Million) Table 42. Asia-Pacific Musculoskeletal Medicine Market Size by Region (2017-2022) & (US$ Million) Table 43. Asia-Pacific Musculoskeletal Medicine Market Size by Region (2023-2028) & (US$ Million) Table 44. Latin America Musculoskeletal Medicine Market Size by Country (2017-2022) & (US$ Million) Table 45. Latin America Musculoskeletal Medicine Market Size by Country (2023-2028) & (US$ Million) Table 46. Middle East & Africa Musculoskeletal Medicine Market Size by Country (2017-2022) & (US$ Million) Table 47. Middle East & Africa Musculoskeletal Medicine Market Size by Country (2023-2028) & (US$ Million) Table 48. Mylan N.V. Company Detail Table 49. Mylan N.V. Business Overview Table 50. Mylan N.V. Musculoskeletal Medicine Product Table 51. Mylan N.V. Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 52. Mylan N.V. Recent Development Table 53. Teva Pharmaceutical Industries Ltd Company Detail Table 54. Teva Pharmaceutical Industries Ltd Business Overview Table 55. Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Product Table 56. Teva Pharmaceutical Industries Ltd Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 57. Teva Pharmaceutical Industries Ltd Recent Development Table 58. UCB S.A. Company Detail Table 59. UCB S.A. Business Overview Table 60. UCB S.A. Musculoskeletal Medicine Product Table 61. UCB S.A. Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 62. UCB S.A. Recent Development Table 63. Novartis Pharmaceuticals Company Detail Table 64. Novartis Pharmaceuticals Business Overview Table 65. Novartis Pharmaceuticals Musculoskeletal Medicine Product Table 66. Novartis Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 67. Novartis Pharmaceuticals Recent Development Table 68. Roche Inc Company Detail Table 69. Roche Inc Business Overview Table 70. Roche Inc Musculoskeletal Medicine Product Table 71. Roche Inc Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 72. Roche Inc Recent Development Table 73. Hospira Inc Company Detail Table 74. Hospira Inc Business Overview Table 75. Hospira Inc Musculoskeletal Medicine Product Table 76. Hospira Inc Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 77. Hospira Inc Recent Development Table 78. Valeant Pharmaceuticals International, Inc Company Detail Table 79. Valeant Pharmaceuticals International, Inc Business Overview Table 80. Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Product Table 81. Valeant Pharmaceuticals International, Inc Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 82. Valeant Pharmaceuticals International, Inc Recent Development Table 83. Dr. Reddy's Laboratories Ltd. Company Detail Table 84. Dr. Reddy's Laboratories Ltd. Business Overview Table 85. Dr. Reddy's Laboratories Ltd. Musculoskeletal Medicine Product Table 86. Dr. Reddy's Laboratories Ltd. Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 87. Dr. Reddy's Laboratories Ltd. Recent Development Table 88. Sun Pharmaceutical Industries Ltd. Co. , Ltd Company Detail Table 89. Sun Pharmaceutical Industries Ltd. Co. , Ltd Business Overview Table 90. Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Product Table 91. Sun Pharmaceutical Industries Ltd. Co. , Ltd Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 92. Sun Pharmaceutical Industries Ltd. Co. , Ltd Recent Development Table 93. Sawai PharmaceuticalCo., Ltd Company Detail Table 94. Sawai PharmaceuticalCo., Ltd Business Overview Table 95. Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Product Table 96. Sawai PharmaceuticalCo., Ltd Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 97. Sawai PharmaceuticalCo., Ltd Recent Development Table 98. Endo International Company Detail Table 99. Endo International Business Overview Table 100. Endo International Musculoskeletal MedicineProduct Table 101. Endo International Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 102. Endo International Recent Development Table 103. Hikma Pharmaceuticals Company Detail Table 104. Hikma Pharmaceuticals Business Overview Table 105. Hikma Pharmaceuticals Musculoskeletal MedicineProduct Table 106. Hikma Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 107. Hikma Pharmaceuticals Recent Development Table 108. Fresenius Kabi, LLC Company Detail Table 109. Fresenius Kabi, LLC Business Overview Table 110. Fresenius Kabi, LLC Musculoskeletal MedicineProduct Table 111. Fresenius Kabi, LLC Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 112. Fresenius Kabi, LLC Recent Development Table 113. Boehringer Ingelheim Company Detail Table 114. Boehringer Ingelheim Business Overview Table 115. Boehringer Ingelheim Musculoskeletal MedicineProduct Table 116. Boehringer Ingelheim Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 117. Boehringer Ingelheim Recent Development Table 118. Merck Company Detail Table 119. Merck Business Overview Table 120. Merck Musculoskeletal MedicineProduct Table 121. Merck Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 122. Merck Recent Development Table 123. GSK Company Detail Table 124. GSK Business Overview Table 125. GSK Musculoskeletal MedicineProduct Table 126. GSK Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 127. GSK Recent Development Table 128. Alter Company Detail Table 129. Alter Business Overview Table 130. Alter Musculoskeletal MedicineProduct Table 131. Alter Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 132. Alter Recent Development Table 133. Bayer Company Detail Table 134. Bayer Business Overview Table 135. Bayer Musculoskeletal MedicineProduct Table 136. Bayer Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 137. Bayer Recent Development Table 138. Rafa Laboratories Company Detail Table 139. Rafa Laboratories Business Overview Table 140. Rafa Laboratories Musculoskeletal MedicineProduct Table 141. Rafa Laboratories Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 142. Rafa Laboratories Recent Development Table 143. Grunenthal Company Detail Table 144. Grunenthal Business Overview Table 145. Grunenthal Musculoskeletal MedicineProduct Table 146. Grunenthal Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 147. Grunenthal Recent Development Table 148. Pfizer Company Detail Table 149. Pfizer Business Overview Table 150. Pfizer Musculoskeletal MedicineProduct Table 151. Pfizer Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 152. Pfizer Recent Development Table 153. Sanofi Company Detail Table 154. Sanofi Business Overview Table 155. Sanofi Musculoskeletal MedicineProduct Table 156. Sanofi Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 157. Sanofi Recent Development Table 158. Italfarmaco Company Detail Table 159. Italfarmaco Business Overview Table 160. Italfarmaco Musculoskeletal MedicineProduct Table 161. Italfarmaco Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 162. Italfarmaco Recent Development Table 163. Martec USA LLC Company Detail Table 164. Martec USA LLC Business Overview Table 165. Martec USA LLC Musculoskeletal MedicineProduct Table 166. Martec USA LLC Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 167. Martec USA LLC Recent Development Table 168. Acorda Therapeutics Company Detail Table 169. Acorda Therapeutics Business Overview Table 170. Acorda Therapeutics Musculoskeletal MedicineProduct Table 171. Acorda Therapeutics Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 172. Acorda Therapeutics Recent Development Table 173. Apotex Inc Company Detail Table 174. Apotex Inc Business Overview Table 175. Apotex Inc Musculoskeletal MedicineProduct Table 176. Apotex Inc Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 177. Apotex Inc Recent Development Table 178. CorePharma Company Detail Table 179. CorePharma Business Overview Table 180. CorePharma Musculoskeletal MedicineProduct Table 181. CorePharma Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 182. CorePharma Recent Development Table 183. Helsinn Company Detail Table 184. Helsinn Business Overview Table 185. Helsinn Musculoskeletal MedicineProduct Table 186. Helsinn Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 187. Helsinn Recent Development Table 188. Therabel Company Detail Table 189. Therabel Business Overview Table 190. Therabel Musculoskeletal MedicineProduct Table 191. Therabel Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 192. Therabel Recent Development Table 193. Sinopharm Company Detail Table 194. Sinopharm Business Overview Table 195. Sinopharm Musculoskeletal MedicineProduct Table 196. Sinopharm Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 197. Sinopharm Recent Development Table 198. Chinoin Company Detail Table 199. Chinoin Business Overview Table 200. Chinoin Musculoskeletal Medicine Product Table 201. Chinoin Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million) Table 202. Chinoin Recent Development Table 203. Research Programs/Design for This Report Table 204. Key Data Information from Secondary Sources Table 205. Key Data Information from Primary Sources List of Figures Figure 1. Global Musculoskeletal Medicine Market Share by Type: 2021 VS 2028 Figure 2. Tablets Features Figure 3. Patch Features Figure 4. Capsule Features Figure 5. Suppositories Features Figure 6. Injection Features Figure 7. Suspension Agent Features Figure 8. Emplastrum Features Figure 9. Granules Features Figure 10. Other Features Figure 11. Global Musculoskeletal Medicine Market Share by Application in 2021 & 2028 Figure 12. Orthopedic Analgesics Case Studies Figure 13. Antipyretic And Analgesic Case Studies Figure 14. Nonsteroidal Anti-Inflammatory Drugs Case Studies Figure 15. Drugs For Rheumatic Diseases Case Studies Figure 16. Gout Drug Resistance Case Studies Figure 17. Medication For Bruising Injuries Case Studies Figure 18. Myasthenia Gravis Medication Case Studies Figure 19. Slow Acting Antirheumatic Agent Case Studies Figure 20. Topical Administration For Joint And Muscle Pain Case Studies Figure 21. Other Case Studies Figure 22. Musculoskeletal Medicine Report Years Considered Figure 23. Global Musculoskeletal Medicine Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 24. Global Musculoskeletal Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 25. Global Musculoskeletal Medicine Market Share by Region: 2021 VS 2028 Figure 26. Global Musculoskeletal Medicine Market Share by Players in 2021 Figure 27. Global Top Musculoskeletal Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Medicine as of 2021) Figure 28. The Top 10 and 5 Players Market Share by Musculoskeletal Medicine Revenue in 2021 Figure 29. North America Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. North America Musculoskeletal Medicine Market Share by Country (2017-2028) Figure 31. United States Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Canada Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Europe Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Europe Musculoskeletal Medicine Market Share by Country (2017-2028) Figure 35. Germany Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. France Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. U.K. Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Italy Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Russia Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Nordic Countries Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Asia-Pacific Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Asia-Pacific Musculoskeletal Medicine Market Share by Region (2017-2028) Figure 43. China Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Japan Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. South Korea Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Southeast Asia Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. India Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Australia Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Latin America Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Latin America Musculoskeletal Medicine Market Share by Country (2017-2028) Figure 51. Mexico Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Brazil Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Middle East & Africa Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Middle East & Africa Musculoskeletal Medicine Market Share by Country (2017-2028) Figure 55. Turkey Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Saudi Arabia Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. Mylan N.V. Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 58. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 59. UCB S.A. Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 60. Novartis Pharmaceuticals Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 61. Roche Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 62. Hospira Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 63. Valeant Pharmaceuticals International, Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 64. Dr. Reddy's Laboratories Ltd. Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 65. Sun Pharmaceutical Industries Ltd. Co. , Ltd Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 66. Sawai PharmaceuticalCo., Ltd Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 67. Endo International Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 68. Hikma Pharmaceuticals Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 69. Fresenius Kabi, LLC Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 70. Boehringer Ingelheim Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 71. Merck Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 72. GSK Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 73. Alter Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 74. Bayer Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 75. Rafa Laboratories Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 76. Grunenthal Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 77. Pfizer Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 78. Sanofi Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 79. Italfarmaco Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 80. Martec USA LLC Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 81. Acorda Therapeutics Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 82. Apotex Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 83. CorePharma Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 84. Helsinn Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 85. Therabel Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 86. Sinopharm Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 87. Chinoin Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022) Figure 88. Bottom-up and Top-down Approaches for This Report Figure 89. Data Triangulation Figure 90. Key Executives Interviewed

Mylan N.V. Teva Pharmaceutical Industries Ltd UCB S.A. Novartis Pharmaceuticals Roche Inc Hospira Inc Valeant Pharmaceuticals International, Inc Dr. Reddy's Laboratories Ltd. Sun Pharmaceutical Industries Ltd. Co. , Ltd Sawai PharmaceuticalCo., Ltd Endo International Hikma Pharmaceuticals Fresenius Kabi, LLC Boehringer Ingelheim Merck GSK Alter Bayer Rafa Laboratories Grunenthal Pfizer Sanofi Italfarmaco Martec USA LLC Acorda Therapeutics Apotex Inc CorePharma Helsinn Therabel Sinopharm Chinoin